<i>miR-449a</i>: A Novel Biomarker for Diagnosis, Prognosis, and Treatment Response in Locally Advanced Laryngeal Squamous Cell Carcinoma
<i>miR-449a</i> serves as a non-invasive biomarker for LA-LSCC diagnosis, prognosis, and treatment monitoring. Its dynamic expression highlights potential for risk stratification and therapy response prediction, warranting further validation in larger cohorts.
Authors
- Hayaa M. Alhuthali (ORCID: https://orcid.org/0000-0001-5999-081X)
- Amal F. Gharib (ORCID: https://orcid.org/0000-0001-8008-3368)
- Rasha L. Etewa
- Wael H. Elsawy (ORCID: https://orcid.org/0000-0003-4938-6883)
- Afaf Alharthi (ORCID: https://orcid.org/0000-0002-4171-9850)
- Saud Ayed Alharthi
- Ohud Alsalmi (ORCID: https://orcid.org/0009-0003-3892-4110)
- Shaimaa A Alharthi (ORCID: https://orcid.org/0009-0009-8826-4951)
Institutions
- Taif University (SA)
- Zagazig University (EG)
- Jouf University (SA)
- Soliman Fakeeh Hospital (SA)
- King Abdulaziz Hospital (SA)
Publication Details
- Journal
- Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics
- Published
- 2025-12-18
- DOI
- https://doi.org/10.32604/or.2025.073051
- Primary Topic
- Head and Neck Cancer Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Taif University